Clifford Crane and Apollo Security Sales, combining efforts with Smart Media Innovations (SMI), have introduced their latest innovation in top-of-the-line security. The new mobile reader will allow top security to go anywhere.
Michael G. Kurilla, Director of the Office of BioDefense Research Affairs at NIAID, NIH will give a featured presentation on "Novel, Antiviral Host Based Targeting Influencing Drug Development" at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
Neil S. Ryder, Executive Director of Infectious Diseases at Novartis Institutes for BioMedical Research will give a featured presentation on "Opportunities and Challenges for Novel Antifungal Therapies" at the 8th Anti-infectives Partnering and Deal-making Conference to be held in Boston, MA on November 7-8, 2011 by GTC.
UBIFRANCE, the French Trade Commission in London, will be hosting a stand at BioPartnering Europe (BPE) 2011, which will take place at the Queen Elizabeth II Conference Centre, in London, from 9 to 11 October. UBIFRANCE will accompany a range of French companies at the event and will be situated on Exhibit Booth 10.
William R. Strohl, Vice President of Biologics Research at Johnson & Johnson, will give a plenary keynote presentation on "The Future of Antibodies and Antibody-Like Protein Therapeutics" at the 7th Modern Drug Discovery and Development Summit to be held in San Diego, CA on October 19-21, 2011 by GTC.
Carol A. Pratt, Ph.D. and Janet M. McNicholas, Ph.D. of K&L Gates to give a featured presentation entitled "Biosimilars: Coordinating FDA and Patent Strategies" at GTC's 4th Protein Discovery & Therapeutics Conference on Oct 19-21, 2011 in San Diego, CA.
Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation on "Novel Approaches to Inhibit Kinases: The IGF1R Case" at the 5th Drug Design and Medicinal Chemistry Conference to be held in San Diego, CA on October 19-21, 2011 by GTC.
Susan Siegel Ph.D. and William Noonan M.D. of Klarquist Sparkman to give a featured presentation entitled "Patenting Protein Therapeutics: In the Shadow of Uncertainty" at GTC's 4th Protein Discovery & Therapeutics Conference on Oct 19-21, 2011 in San Diego, CA.
With AAALAC and OLAW accredited animal facilities, GenScript has established multiple in vivo platforms to provide the comprehensive services, including in vivo drug efficacy evaluation, pharmacokinetic study, toxicity assessment and biomarker & bioanalysis service.
ONET TECHNOLOGIES UK Ltd (OTUK) has agreed to manufacture specialised hot cells for the production and commercialization of ALPHARADIN (radium-223 chloride). Developed by ALGETA SAS of Norway, ALPHARADIN is a highly targeted alpha-pharmaceutical, currently under clinical evaluation, which is intended to improve survival in patients with bone metastases from advanced cancer.
Greenier Biotechnologies has picked a site for its first testing facility-a move that could put Greenier on the map for producing alternative energy solutions.
To access and search the world's largest commercial ORF clone database, GenScript is proud to offer a Search Add-on for Firefox. Concurrent with the GenScript Search add-on expansion, you could get your reward till Sep 30th, 2011.
Klaus D. Mendla, Head of Global Business Development and Licensing CNS at Boehringer Ingelheim, will give a featured presentation on "Sincerely, Yours - Partnering with Boehringer Ingelheim in the CNS Space" at the 4th CNS Partnering and Deal-making Conference to be held in San Francisco, CA on September 22-23, 2011 by GTC.
Dr. Kanta Subbarao, Chief of Emerging Respiratory Viruses Section at the National Institute of Allergy and Infectious Diseases, National Institute of Health, to deliver keynote presentation at the "9th Annual Vaccines Discovery and Development: All Things Considered" conference, to be held on Nov. 7-8, 2011 in Boston, MA by GTC.
Next generation innovative proteins and enzymes will be developed by combining Evozym Biologics' innovative enzyme/protein design capabilities with GenScript's gene synthesis and protein expression capabilities.
Dr. Alamgir Hossain, principal plant breeder at Bangladesh Rice Research Institute blogs about breeding hardy, high-yielding, and nutritious Golden Rice for Bangladesh.
Biotage (STO: BIOT), announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy.
GenScript has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System. The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved previous version with a totally re-designed, stylish and durable protein staining device (L02016) of extended lifetime.
SeeWhy, Inc., the company that boosts website conversion with real-time remarketing, today announced a complimentary webinar to discuss how small changes to an ecommerce website and its conversion rate can have a dramatic impact on sales.
Labor Berlin (Charité Vivantes GmbH) and bioMérieux announce the signature of an agreement to create a Centre of Excellence for microbiology and enhanced laboratory automation. The centre will be located at Europe's largest hospital laboratory, serving more than 8,000 in-house patients in Berlin and handling over 23 million patient analys
GenScript USA Inc. has launched new websites at www.genscript.fr in France and at www.genscript.es in Spain to offer easier access for local French and Spanish searchers.
Satisfied Users & 
Approved Press Releases
